In addition to MAergic neurodegeneration, AD is associated with significant loss of the Ach neurotransmitter system, characterized by the loss of forebrain Ach afferents and the selective loss of cholinergic neurons in the subcortical forebrain regions, including the nucleus basalis Meynert (NbM) [1]. This evidence concerns the gene FGFR3 and Alzheimer disease.